(Reuters) – Wall Street futures were mixed on Friday after Federal Reserve Chair Jerome Powell’s hawkish tone dampened hopes of an end to rate hikes, with investors now looking forward to next week’s economic reports for more cues on the monetary policy path.
Powell on Thursday said central bank officials “are not confident” that interest rates are yet high enough to finish the battle with inflation and would not hesitate to tighten policy further if needed.
The hawkish comments sent U.S. Treasury yields surging and ended a strong run of gains on Wall Street which had been driven by expectations that the Fed was done with its hiking cycle after the central bank kept rates unchanged at its last meeting.
The and the Nasdaq snapped their longest winning streak in two years in the previous session.
At 5:17 a.m. ET, were up 53 points, or 0.16%, were up 0.25 points, or 0.01%, and were down 29.5 points, or 0.19%.
“With markets having been remarkably jittery in the wake of Powell’s appearance, the market confidence seen of late clearly stands on relatively unstable presumptions,” said Joshua Mahony, chief market analyst at Scope Markets.
However, with inflation likely to continue its downward trend, “there is a strong chance that we see rates remain steady from here on in,” Mahony adds.
Traders have priced in an about 60% chance of a rate cut by the Fed at the June meeting compared to about 70% before Powell spoke, according to the CME Group’s (NASDAQ:) FedWatch tool.
While this week has been light in terms of economic data, investors will get reports on consumer and producer prices as well as retail sales next week, which will further shape interest rate expectations ahead of the Fed’s December meeting.
The University of Michigan is set to issue a preliminary reading on its consumer sentiment index for November at 10 a.m. ET.
Megacap growth stocks Alphabet (NASDAQ:), Nvidia (NASDAQ:) and Tesla (NASDAQ:) fell between 0.5% and 1.5% in premarket trading.
Among individual stocks, Plug Power (NASDAQ:) slumped 28.8% after the hydrogen fuel-cell firm’s third-quarter revenue missed estimates.
Illumina (NASDAQ:) shares dropped 11.2% as the gene-testing company trimmed its full-year profit forecast for the second straight quarter.
Read the full article here